1.
Kardiologiia
; 15(9): 74-7, 1975 Sep.
Artigo
em Russo
| MEDLINE
| ID: mdl-1230529
RESUMO
A study of 152 patients with transmural or large-focal myocardial infarction was conducted; 82 of them received low doses of Obsidan (40 mg/day) for 14 days during the activization period. The employment of such doses of the drug was found rational for ensuring a more effective activization of the patients who had a persistent pain syndrome, sinus tachycardia, extrasystolic arrhythmias and "ischaemic" changes of ECG in response to definite stages of the kinetic regimen. A decrease of cardiac output noted during the therapy was especially distinct in cases of cardiac aneurysms and corresponded to the alternating conditions of the metabolic processes.